Vivos Therapeutics, Inc. SEC filings VVOS

Vivos Therapeutics, Inc. has 301 filings in SEC EDGAR's recent list, going back to Sep 28, 2017. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.

Vivos Therapeutics, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 27, 2026 Sep 14, 2026
4 Insider transaction Oct 26, 2026 Sep 14, 2026
4 Insider transaction Oct 26, 2026 Sep 14, 2026
4 Insider transaction Sep 18, 2026 Sep 14, 2026
4 Insider transaction Sep 18, 2026 Sep 14, 2026
4 Insider transaction Sep 18, 2026 Jun 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Sep 3, 2026 —
4 Insider transaction Aug 26, 2026 Jul 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 11, 2026 —
SCHEDULE 13D Ownership over 5% (active) Jul 15, 2026 —
4 Insider transaction Jul 15, 2026 Jun 30, 2026
3 Initial insider ownership Jul 15, 2026 Jun 30, 2026
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
3 Initial insider ownership Apr 10, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
SCHEDULE 13D Ownership over 5% (active) Apr 2, 2026 —
3 Initial insider ownership Feb 13, 2026 Feb 4, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 14, 2025 —
3 Initial insider ownership Jun 20, 2025 Jun 9, 2025
SCHEDULE 13D Ownership over 5% (active) Jun 16, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Dec 30, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Dec 20, 2024 —
4 Insider transaction Nov 27, 2024 Nov 26, 2024
4 Insider transaction Nov 27, 2024 Nov 26, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Sep 24, 2024 —
4 Insider transaction Jun 28, 2024 Jun 20, 2024
4 Insider transaction Jun 28, 2024 Jun 20, 2024
4 Insider transaction Jun 28, 2024 Jun 20, 2024
4 Insider transaction Jun 28, 2024 Jun 20, 2024
4 Insider transaction Jun 28, 2024 Jun 20, 2024
4 Insider transaction Jun 28, 2024 Jun 20, 2024
4 Insider transaction Jun 28, 2024 Jun 20, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
4 Insider transaction Jun 20, 2023 Jun 20, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 15, 2023 Jun 14, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2023 —
4 Insider transaction Dec 28, 2022 Dec 23, 2022
4 Insider transaction Dec 28, 2022 Dec 23, 2022
4 Insider transaction Dec 28, 2022 Dec 23, 2022
4 Insider transaction Dec 28, 2022 Dec 23, 2022
4 Insider transaction Dec 28, 2022 Dec 23, 2022
4 Insider transaction Dec 28, 2022 Dec 23, 2022
4 Insider transaction Dec 28, 2022 Dec 23, 2022
4 Insider transaction Jun 3, 2022 May 31, 2022
4 Insider transaction Feb 28, 2022 Feb 25, 2022
4 Insider transaction Feb 28, 2022 Feb 25, 2022
5 Annual insider ownership Feb 14, 2022 Dec 31, 2021
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
4 Insider transaction Sep 22, 2021 Sep 21, 2021
4 Insider transaction Sep 2, 2021 Aug 31, 2021
4 Insider transaction Aug 18, 2021 Aug 17, 2021
4 Insider transaction Aug 10, 2021 Aug 5, 2021
4 Insider transaction Aug 10, 2021 Aug 5, 2021
4 Insider transaction Aug 10, 2021 Aug 5, 2021
4 Insider transaction Aug 10, 2021 Aug 5, 2021
4 Insider transaction Aug 10, 2021 Aug 5, 2021
4 Insider transaction Aug 10, 2021 Aug 5, 2021
3/A Filing Jun 29, 2021 Dec 10, 2020
4 Insider transaction May 25, 2021 May 25, 2021
4 Insider transaction May 25, 2021 May 25, 2021
4 Insider transaction Mar 17, 2021 Mar 12, 2021
SC 13G Ownership over 5% (passive) Feb 16, 2021 —
SC 13G Ownership over 5% (passive) Feb 16, 2021 —
4 Insider transaction Dec 28, 2020 Dec 24, 2020
4 Insider transaction Dec 23, 2020 Dec 23, 2020
4 Insider transaction Dec 14, 2020 Dec 11, 2020
3 Initial insider ownership Dec 10, 2020 Dec 10, 2020
3 Initial insider ownership Dec 10, 2020 Dec 10, 2020
3 Initial insider ownership Dec 10, 2020 Dec 10, 2020
3 Initial insider ownership Dec 10, 2020 Dec 10, 2020
3 Initial insider ownership Dec 10, 2020 Dec 10, 2020
3 Initial insider ownership Dec 10, 2020 Dec 10, 2020
3 Initial insider ownership Dec 10, 2020 Dec 10, 2020
3 Initial insider ownership Dec 10, 2020 Dec 10, 2020

Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
VVOS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Littleton, CO
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1716166
Former names
Vivos BioTechnologies, Inc. (until Sep 29, 2017)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.